Huron Consulting (HURN)
NASDAQ:HURN
Want to see HURN full AI Analyst Report?
Top Page
Huron Consulting
(NASDAQ:HURN)
Select Model
Select Model
Rating:72Outperform
Price Target:
$133.00
▲(2.97% Upside)
Action:ReiteratedDate:05/07/26
The score is driven primarily by solid financial performance (growth, profitability recovery, and strong 2025 cash generation) and supportive earnings-call fundamentals with reaffirmed 2026 guidance and strong demand signals. The rating is held back by weak technical positioning (trading below major moving averages) and a moderate valuation (P/E ~23.3) without a provided dividend yield.
Positive Factors
Sustained Revenue Growth & Strong Demand
Multi-year revenue expansion to $1.7B and >20% trailing six-month bookings, plus record healthcare RBR, signal durable end-market demand and backlog-driven revenue visibility. This supports predictable utilization and project pipelines over the next several quarters.
Negative Factors
Elevated Short-Term Leverage
Leverage at 3.1x following Q1 increases constrains financial flexibility and raises refinancing and covenant risk until reduced to the 2.0x–2.5x target. Material deleveraging will be required over ensuing quarters to restore balance sheet headroom and optionality.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth & Strong Demand
Multi-year revenue expansion to $1.7B and >20% trailing six-month bookings, plus record healthcare RBR, signal durable end-market demand and backlog-driven revenue visibility. This supports predictable utilization and project pipelines over the next several quarters.
Read all positive factors
Huron Consulting (HURN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.95B
Dividend YieldN/A
Average Volume (3M)240.67K
Price to Earnings (P/E)23.3
Beta (1Y)0.74
Revenue Growth11.79%
EPS Growth-13.03%
CountryUS
Employees6,405
SectorIndustrials
Sector Strength72
IndustryConsulting Services
Share Statistics
EPS (TTM)6.02
Shares Outstanding16,576,712
10 Day Avg. Volume229,731
30 Day Avg. Volume240,670
Financial Highlights & Ratios
PEG Ratio-3.74
Price to Book (P/B)5.71
Price to Sales (P/S)1.78
P/FCF Ratio16.49
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue1.22
Enterprise Value/Gross Profit3.92
Enterprise Value/Ebitda9.44
Forecast
1Y Price Target
$166.33Price Target Upside28.77% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)8.8
Revenue Forecast (FY)$1.82B
Huron Consulting Business Overview & Revenue Model
Company Description
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Business Advisory, and Education. The Healthcare segment provides ad...
How the Company Makes Money
Huron primarily makes money by billing clients for professional services delivered through consulting engagements and, where applicable, ongoing managed services. Revenue is largely generated from (1) time-and-materials and other fee-based consult...
Huron Consulting Earnings Call Summary
Earnings Call Date:May 05, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Jul 30, 2026
Earnings Call Sentiment Positive
The call conveyed solid top-line growth, margin expansion, record healthcare performance, strong bookings and backlog, and confidence in AI-driven opportunities—leading management to reaffirm full-year guidance. Offsetting items include significant Q1 cash outflows (annual bonuses and buybacks) that produced negative free cash flow, higher net debt and leverage (3.1x), rising corporate costs, and some digital revenue softness and timing-related DSO increases. Management signaled they will moderate repurchases and target leverage reduction to the low twos by year-end.Positive Updates
Strong Overall Revenue Growth (RBR)
Revenues before reimbursable expenses (RBR) were $443.7M in Q1 2026, up 12.1% versus $395.7M in Q1 2025, driven by growth across health care, education, and commercial segments.
Negative Updates
Negative Free Cash Flow and Large Cash Usage
Q1 operating cash flow used $162.2M (versus $106.8M in Q1 2025) and free cash flow was negative $174.1M in Q1 2026, driven by annual incentive payments and capital spending.
Read all updates
Q1-2026 Updates
Positive
Negative
Strong Overall Revenue Growth (RBR)
Revenues before reimbursable expenses (RBR) were $443.7M in Q1 2026, up 12.1% versus $395.7M in Q1 2025, driven by growth across health care, education, and commercial segments.
Read all positive updates
Company Guidance
Management affirmed 2026 guidance, reiterating RBR of $1.78–$1.86 billion, adjusted EBITDA of 14.5%–15.0% of RBR, and adjusted (non‑GAAP) diluted EPS of $8.35–$9.15; they also expect a full‑year effective tax rate of about 28%–30%, positive free cash flow of $180–$220 million (net of cash taxes and interest, excluding noncash stock‑based comp), and a year‑end leverage target of 2.0x–2.5x adjusted EBITDA (after a seasonal Q1 leverage of 3.1x). Management reiterated disciplined capital allocation—continued programmatic tuck‑in M&A (M&A contribution to growth ~2%–4%, likely toward the lower end) and ongoing share repurchases (Q1 buybacks were $155.5M, ~1.1M shares).Huron Consulting Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
86
Very Positive
Cash Flow
83
Very Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.70B | 1.49B | 1.36B | 1.13B | 905.64M |
| Gross Profit | 508.79M | 476.01M | 419.36M | 346.57M | 268.86M |
| EBITDA | 201.71M | 184.29M | 159.69M | 133.18M | 87.80M |
| Net Income | 105.04M | 116.63M | 62.48M | 75.55M | 62.99M |
Balance Sheet | |||||
| Total Assets | 1.53B | 1.34B | 1.26B | 1.20B | 1.12B |
| Cash, Cash Equivalents and Short-Term Investments | 24.51M | 21.91M | 12.15M | 11.83M | 20.78M |
| Total Debt | 548.34M | 398.61M | 373.88M | 346.09M | 297.24M |
| Total Liabilities | 998.05M | 782.29M | 729.25M | 647.00M | 547.45M |
| Stockholders Equity | 528.63M | 561.33M | 532.89M | 552.04M | 571.90M |
Cash Flow | |||||
| Free Cash Flow | 182.96M | 192.67M | 100.08M | 61.10M | 2.23M |
| Operating Cash Flow | 193.39M | 201.32M | 135.26M | 85.40M | 17.99M |
| Investing Cash Flow | -145.75M | -79.75M | -36.65M | -20.13M | -20.14M |
| Financing Cash Flow | -45.03M | -111.64M | -98.33M | -74.11M | -44.41M |
Huron Consulting Technical Analysis
Neutral
129.17
Price Trends
133.47
Negative
153.85
Negative
148.91
Negative
Market Momentum
-1.53
Negative
48.27
Neutral
71.90
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HURN, the sentiment is Neutral. The current price of 129.17 is above the 20-day moving average (MA) of 127.30, below the 50-day MA of 133.47, and below the 200-day MA of 148.91, indicating a neutral trend. The MACD of -1.53 indicates Negative momentum. The RSI at 48.27 is Neutral, neither overbought nor oversold. The STOCH value of 71.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HURN.
Huron Consulting Risk Analysis
Huron Consulting disclosed 34 risk factors in its most recent earnings report. Huron Consulting reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Huron Consulting Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $3.16B | 28.02 | 27.94% | 1.66% | 7.82% | 4.63% | |
72 Outperform | $1.95B | 23.29 | 21.83% | ― | 11.79% | -13.03% | |
72 Outperform | $4.85B | 24.15 | 15.14% | ― | 5.60% | 14.32% | |
70 Outperform | $986.35M | 24.89 | 26.10% | 0.97% | 9.33% | 20.44% | |
65 Neutral | $1.33B | 22.56 | 9.11% | 0.65% | -7.27% | -15.40% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | $148.99M | -3.31 | -49.24% | 6.74% | -13.38% | 9.50% |
* Industrials Sector Average
HURN
Huron Consulting
120.11
-32.15
-21.12%
CRAI
Cra International
152.64
-30.62
-16.71%
EXPO
Exponent
64.21
-11.75
-15.46%
FCN
FTI Consulting
160.99
-5.83
-3.49%
ICFI
Icf International
73.58
-13.25
-15.26%
RGP
Resources Connection
4.34
-0.96
-18.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.